Smith Nephew reported 441M in Pre-Tax Profit for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abiomed ABMD:US $ 74.76M 16.89M
Accuray ARAY:US $ -0.64M 1.3M
Atricure ATRC:US $ -15.13M 1.44M
Cardiovascular Systems CSII:US $ -9.6M 0.69M
Edwards Lifesciences EW:US $ 440.8M 73.9M
Fresenius FRE:GR € 784M 217M
GN Store Nord GN:DC DK -227M 767M
Hologic HOLX:US $ 659.1M 47.5M
Idexx Laboratories IDXX:US $ 241.49M 49.61M
Inogen INGN:US $ -13.99M 7.1M
Insulet PODD:US $ 29.3M 4.1M
Intuitive Surgical ISRG:US $ 544.7M 3.3M
Johnson & Johnson JNJ:US $ 8218M 1879M
Masimo MASI:US $ 70.01M 14.29M
Resmed RMD:US $ 245.03M 11.22M
Smith Nephew SNN:US 441M 25M
Stryker SYK:US $ 757M 483.4M
Teleflex TFX:US $ 155.04M 43.36M
William Demant Holding WDH:DC 1.71B 171M
Zimmer Biomet Holdings Inc ZBH:US $ 342M 136.3M